| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 08/20/2009 | US20090209505 Prodrugs of heteroaryl compounds |
| 08/20/2009 | US20090209451 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes |
| 08/20/2009 | US20090208449 Heterocyclic antiviral compounds |
| 08/20/2009 | CA2715839A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors |
| 08/20/2009 | CA2715559A1 Hepatitis c virus inhibitors |
| 08/20/2009 | CA2715550A1 Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors |
| 08/20/2009 | CA2714087A1 Inhibitors of checkpoint kinases |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP2089373A1 Stat3/5 activation inhibitor |
| 08/19/2009 | EP2089367A1 Pyrazoline compounds as mineralocorticoid receptor antagonists |
| 08/19/2009 | EP2035394B1 2-pyrazinecarboxamide derivatives |
| 08/19/2009 | EP1718617B1 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators |
| 08/19/2009 | EP1689712B1 4-phenylpiperidine derivatives as renin inhibitors |
| 08/19/2009 | EP1590334B1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
| 08/19/2009 | EP1436286B1 Fumagillol derivatives and preparing method thereof |
| 08/19/2009 | EP1183240B1 Beta2-adrenoceptor agonists |
| 08/19/2009 | CN101511852A Synthesis of diethyl{ i5'' (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 08/19/2009 | CN101511825A Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (GSK3) |
| 08/19/2009 | CN101511824A Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (GSK3) |
| 08/19/2009 | CN101511800A Triazolyl phenyl benzenesulfonamides |
| 08/19/2009 | CN101511354A Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral disorders |
| 08/19/2009 | CN100528878C Tetrahydroquinoline derivatives and a process for preparing the same |
| 08/19/2009 | CN100528868C Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives |
| 08/19/2009 | CN100528846C Amine compounds and use thereof |
| 08/18/2009 | US7576221 Substituted imidazole derivatives |
| 08/18/2009 | US7576215 Anticholesterol agents; antidiabetic agents; cardiovascular disorders ; antiarthritic agents |
| 08/18/2009 | US7576209 Breast, prostate and ovarian cancer; such as 1-[4-(9-phenyl-3-pyrimidin-2-yl[1,2,4]triazolo[3,4-f]-1,6-naphthyridin-8-yl)phenyl]cyclobutanamine; serine/threonine kinase (Akt) suppression |
| 08/18/2009 | US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS |
| 08/18/2009 | US7576130 Tetramethyltetradecanetetraols as anticarcinogenic, anticholesterol, antidiabetic and hypotensive agents; metabolic disorders, peroxisome proliferator activated receptor associated disorder, Alzheimer's Disease, obesity, pancreatitis; increased HDL levels and lowers LDL levels; combination therapy |
| 08/18/2009 | US7576129 Carboxylic acid compounds |
| 08/18/2009 | US7576114 6-(4-Bromo-2-chloro-phenylamino)-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide; anticarcinogenic, antiproliferative, and antiinflammatory agents; mitogen-activated protein kinase inhibitors |
| 08/18/2009 | US7576107 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-cyano-5-(2-methoxyethylamino)4-trifluoromethylsulfonylpyrazole; insecticides; widen the spectrum of the pesticides; control of parasites in animals |
| 08/18/2009 | US7576104 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases |
| 08/18/2009 | US7576097 Crystalline form of maraviroc |
| 08/18/2009 | US7576088 Benzodioxole derivatives |
| 08/18/2009 | US7576086 N1-benzyl-N4-(phenylpropane-2-yl-3-ol)piperazine; triple action on hydroxytryptamine (5-HT), noradrenalin (NA)and dopamine(DA); on brain synapses; cytochrome P-450 monooxygenase enzyme system antagonists; enzyme inhibitors; side effect reduction |
| 08/18/2009 | US7576079 Viral polymerase inhibitors |
| 08/18/2009 | US7576076 1-Methyl,2,6-dioxo,4-(4-(ethyloxycarbony)piperazin-1-yl-),5-(3-trifluoromethylphenyl)methyl-)-1,2,3,6-tetrahydropyrimidine; antagonist, antagonism; psychoses; antidepressants; schizophrenia; psychological disorders; Alzheimer's disease; neurodegenerative diseases;drug abuse, drug dependence (cocaine) |
| 08/18/2009 | US7576074 Receptor-type kinase modulators and methods of use |
| 08/18/2009 | US7576063 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 08/18/2009 | CA2393568C Diarylmethylpiperazines |
| 08/18/2009 | CA2392030C Urea compounds having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2392028C Carbamate derivatives having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2239282C Fused isoindolones as inhibitors of protein kinase c |
| 08/13/2009 | WO2009100250A1 Chromene derivatives and use thereof as hif hydroxylase activity inhibitors |
| 08/13/2009 | WO2009099982A1 2-aminopyridine kinase inhibitors |
| 08/13/2009 | WO2009099177A1 Amino imidazole derivative |
| 08/13/2009 | WO2009099133A1 Compound having carbazolyl group and use thereof |
| 08/13/2009 | WO2009099087A1 Benzylpiperizine compound |
| 08/13/2009 | WO2009098206A1 Molecules comprising a bis(heteroaryl)maleimide backbone, and use thereof in the inhibition of dde/ddd enzymes |
| 08/13/2009 | WO2009097998A1 Arylchalcogeno-arylalkyl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| 08/13/2009 | WO2009051660A3 Compounds for activating tgf-beta signaling |
| 08/13/2009 | WO2009050201A3 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof |
| 08/13/2009 | WO2009041705A9 5-membered heterocyclic compounds as proton pump inhibitors |
| 08/13/2009 | WO2009030224A3 Novel quinazoline compounds and the use thereof for treating cancerous diseases |
| 08/13/2009 | WO2009024341A3 Condensed anthran i lami de derivatives as insectisides |
| 08/13/2009 | US20090203911 Benzimidazole compound |
| 08/13/2009 | US20090203743 Small molecule entry inhibitors |
| 08/13/2009 | US20090203702 INHIBITORS OF p38 |
| 08/13/2009 | US20090203700 Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi, and Compositions Comprising Them |
| 08/13/2009 | US20090203696 Aryl- and Heteroaryl-Ethyl-Acylguanidine Derivatives, Their Preparation and Their Application in Therapeutics |
| 08/13/2009 | US20090203686 Aminoalkyl-Amidomethyl-Substituted 2-(4-Sulphonylamino)- 3-Hydroxy-3,4-Dihydro-2H-Chroman-6-yl Derivatives |
| 08/13/2009 | US20090203685 Anti-proliferative compounds from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
| 08/13/2009 | US20090202921 Optical recording composition and holographic recording medium |
| 08/13/2009 | CA2715483A1 Molecules comprising a bis(heteroaryl)maleimide backbone, and use thereof in the inhibition of dde/ddd enzymes |
| 08/13/2009 | CA2713855A1 Benzylpiperizine compound |
| 08/12/2009 | EP2088141A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same |
| 08/12/2009 | EP2086960A1 Novel inhibitors of glutaminyl cyclase |
| 08/12/2009 | EP2086947A1 Pyrimidines and their use as cxcr2 receptor antagonists |
| 08/12/2009 | EP2086942A2 Novel compounds |
| 08/12/2009 | EP2086938A1 Organic compounds |
| 08/12/2009 | EP1819681B1 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia |
| 08/12/2009 | EP1483255B1 Process for synthesizing chiral n-aryl piperazines |
| 08/12/2009 | EP1385514B9 Spiroindene and spiroindane compounds |
| 08/12/2009 | EP1343760B1 Muscarinic antagonists |
| 08/12/2009 | EP1224170B1 6-position substituted indoline, production and use thereof as a medicament |
| 08/12/2009 | CN101506224A Peptide epoxyketones for proteasome inhibition |
| 08/12/2009 | CN101506200A Substituted furyl sulfonylamino(thio)carbonyl triazoline(thi)ones |
| 08/12/2009 | CN101506199A Azetidine compounds as orexin receptor antagonists |
| 08/12/2009 | CN101506198A Substituted bicyclic and tricyclic thrombin receptor antagonists |
| 08/12/2009 | CN101506195A New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds |
| 08/12/2009 | CN101506165A Phenyl, pyridine and quinoline derivatives |
| 08/12/2009 | CN101503404A Preparation of 3-substituted-3-hydroxy-indole-2-ketone bis-heterocyclic derivative |
| 08/12/2009 | CN101503402A 2-aniline pyrimidine derivative, as well as preparation and uses thereof |
| 08/12/2009 | CN100526323C 铑和铱的络合物 Complexes of rhodium and iridium |
| 08/12/2009 | CN100526308C Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/12/2009 | CN100526298C Amide derivative and medicine |
| 08/12/2009 | CN100526296C Method for purifying and enriching benzene acryloyl 5- hydroxytryptamine derivant in safflower seed |
| 08/12/2009 | CN100525766C (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 08/12/2009 | CN100525763C Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 08/11/2009 | US7572917 Condensation of silicon compounds with aldehydes in the presence of titanium catalysts in solvents, then reducing and hydolyzing to form drugs used for prophylaxis of atherosclerosis or as enzyme inhibitors |
| 08/11/2009 | US7572915 Quinoline derivatives as phosphodiesterase inhibitors |
| 08/11/2009 | US7572914 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
| 08/11/2009 | US7572813 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 08/11/2009 | US7572806 PPAR active compounds |
| 08/11/2009 | US7572796 excitatory amino acid antagonists for treating neurodegenerative diseases as cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischaemia, infarction, psychoses; 6-{3-[4-(4-fluorobenzyl)-1-piperidyl]propyl}-1H-indole-3-carbonitrile |
| 08/11/2009 | US7572786 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/11/2009 | US7572785 Substituted imidazoles as cannabinoid receptor modulators |